Search Results - "Ledesma, Maria D."

  • Showing 1 - 15 results of 15
Refine Results
  1. 1

    New paradigms for the treatment of lysosomal storage diseases: targeting the endocannabinoid system as a therapeutic strategy by Schuchman, Edward H, Ledesma, Maria D, Simonaro, Calogera M

    Published in Orphanet journal of rare diseases (25-03-2021)
    “…Over the past three decades the lysosomal storage diseases have served as model for rare disease treatment development. While these efforts have led to…”
    Get full text
    Journal Article
  2. 2

    Apolipoprotein D-mediated preservation of lysosomal function promotes cell survival and delays motor impairment in Niemann-Pick type A disease by Pascua-Maestro, Raquel, Corraliza-Gomez, Miriam, Fadrique-Rojo, Cristian, Ledesma, Maria D., Schuchman, Edward H., Sanchez, Diego, Ganfornina, Maria D.

    Published in Neurobiology of disease (01-10-2020)
    “…Lysosomal Storage Diseases (LSD) are genetic diseases causing systemic and nervous system dysfunction. The glia-derived lipid binding protein Apolipoprotein D…”
    Get full text
    Journal Article
  3. 3

    Pharmacological reversion of sphingomyelin‐induced dendritic spine anomalies in a Niemann Pick disease type A mouse model by Arroyo, Ana I, Camoletto, Paola G, Morando, Laura, Sassoe‐Pognetto, Marco, Giustetto, Maurizio, Van Veldhoven, Paul P, Schuchman, Edward H, Ledesma, Maria D

    Published in EMBO molecular medicine (01-03-2014)
    “…Understanding the role of lipids in synapses and the aberrant molecular mechanisms causing the cognitive deficits that characterize most lipidosis is necessary…”
    Get full text
    Journal Article
  4. 4

    Detergent resistant membrane-associated IDE in brain tissue and cultured cells: Relevance to Aβ and insulin degradation by Bulloj, Ayelén, Leal, María C, Surace, Ezequiel I, Zhang, Xue, Xu, Huaxi, Ledesma, Maria D, Castaño, Eduardo M, Morelli, Laura

    Published in Molecular neurodegeneration (31-12-2008)
    “…Abstract Background Insulin degrading enzyme (IDE) is implicated in the regulation of amyloid β (Aβ) steady-state levels in the brain, and its deficient…”
    Get full text
    Journal Article
  5. 5

    Seladin-1/DHCR24 Is Neuroprotective by Associating EAAT2 Glutamate Transporter to Lipid Rafts in Experimental Stroke by Hernández-Jiménez, Macarena, Martínez-López, Diego, Gabandé-Rodríguez, Enrique, Martín-Segura, Adrian, Lizasoain, Ignacio, Ledesma, María D, Dotti, Carlos G, Moro, María A

    Published in Stroke (1970) (01-01-2016)
    “…BACKGROUND AND PURPOSE—3β-Hydroxysteroid-Δ24 reductase (DHCR24) or selective alzheimer disease indicator 1 (seladin-1), an enzyme of cholesterol biosynthetic…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

    Detergent resistant membrane-associated IDE in brain tissue and cultured cells: Relevance to Abeta and insulin degradation by Bulloj, Ayelén, Leal, María C, Surace, Ezequiel I, Zhang, Xue, Xu, Huaxi, Ledesma, Maria D, Castaño, Eduardo M, Morelli, Laura

    Published in Molecular neurodegeneration (31-12-2008)
    “…Insulin degrading enzyme (IDE) is implicated in the regulation of amyloid beta (Abeta) steady-state levels in the brain, and its deficient expression and/or…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Dephosphorylation of tau protein from Alzheimer's disease patients by Szücs, K, Ledesma, M D, Dombrádi, V, Gergely, P, Avila, J, Friedrich, P

    Published in Neuroscience letters (03-01-1994)
    “…Tau protein-prepared post-mortem from brains of Alzheimer's disease patients was treated with protein phosphatase 1 catalytic subunit, 2A catalytic subunit,…”
    Get more information
    Journal Article
  14. 14
  15. 15